March 21, 2024

Bionomics Candidate Offers Hope for 13 Million Americans Living with Post-Traumatic Stress

Clinical-stage biotechnology company, Bionomics Limited (Nasdaq: BNOX), is offering hope to the more than 13 million Americans living with post-traumatic stress disorder (PTSD), a debilitating psychiatric condition. The company has released the full dataset analysis from its Phase 2b ATTUNE trial of BNC210 in patients with PTSD, which showed that BNC210 demonstrated a statistically significant… [Read More]
March 21, 2024

PRISM Market Moves on Thursday: Guess? Climbs; Papa John’s, Shake Shack Slide on CEO News

US equities are trading higher on Thursday at midday after stocks rallied on Wednesday. The S&P crossed 5,200 for the first time and the Dow and Nasdaq also hit all-time highs. Outperformers at midday are software, banks, credit cards, asset managers, homebuilders, machinery, transports, travel/tourism, and auto suppliers. Refiners, managed care, large-cap pharma, P&C insurance,… [Read More]
March 21, 2024

Enveric Biosciences Outlicenses Compounds Generated by AI Drug Discovery System

Enveric Biosciences (Nasdaq: ENVB) has signed three non-binding term sheets with an undisclosed biotechnology company to pursue the out-licensing of three classes of compounds. The compounds are from Enveric’s extensive library of over 1,000 novel molecules generated using the company’s Psybrary™ platform and proprietary computational chemistry and artificial intelligence (AI) drug-discovery system (PsyAI™). “Patients living… [Read More]
March 21, 2024

Stocks making the biggest premarket moves: Micron, Apple, Astera Labs, Broadcom and more

Explore the corporations that made the most striking premarket trading moves: Micron — Semiconductor producer Micron’s shares soared 16.5% after exceeding analyst predictions in fiscal second-quarter earnings and revenue. With earnings of 42 cents per share on $5.82 billion revenue, Micron outperformed LSEG’s expected loss of 25 cents per share on $5.35 billion revenue. Forecasts… [Read More]
March 20, 2024

Clearmind to Commence Clinical Trial in Alcohol-Use Disorder

Psychedelic drug company, Clearmind Medicine Inc. (Nasdaq: CMND), has received approval from the Israeli Ministry of Health to commence its Phase 1/2a clinical trial for alcohol use disorder (AUD) patients. “This is the most important milestone for the company to date and marks our transition to a clinical- stage pharmaceutical company. The Clearmind team has… [Read More]
March 20, 2024

PRISM Market Moves on Wednesday: US Equities Higher; Topgolf, Triumph Group Up; Signet Jewelers, Planet Fitness Stumble

US equities are trading mostly higher in Wednesday afternoon trading after a higher finish on Tuesday. Outperformers include food, apparel manufacturers, beauty, credit cards, and airlines, while jewelry and accessories, fitness, regional banks, tobacco, biotech, life sciences, and energy are weaker. Treasuries are little changed after snapping a six-session losing streak on Tuesday, the Dollar… [Read More]
March 20, 2024

Aurora Cannabis Receives Australian Stamp of Approval

Global medical cannabis company, Aurora Cannabis (Nasdaq: ACB) has received a landmark certification from Australian authorities for cannabis products from its Canadian production facilities. The company announced on Wednesday that it has secured Good Manufacturing Practice (GMP) certification from Australia’s Therapeutic Goods Administration (TGA) for its Canadian production facilities, River and Ridge. The company’s share… [Read More]
March 20, 2024

Stocks making the biggest moves midday: Signet Jewelers, Chipotle, Mobileye Global, Best Buy and more

Stay tuned for the latest business headlines in midday trading. Signet Jewelers — The jewelers’ shares plunged 11% after its disappointing first-quarter revenue guidance which fell short of Wall Street estimates. The firm is anticipating revenue in the ballpark of $1.47 billion and $1.53 billion, a significant drop from the FactSet-predicted earnings of $1.61 billion…. [Read More]